2014
Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplantation: An Interim Assessment.
Kulkarni S, Nancy K, Formica R, Moeckel G, Pober J. Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplantation: An Interim Assessment. Transplantation 2014, 98: 79. DOI: 10.1097/00007890-201407151-00247.Peer-Reviewed Original Research
2006
Ethics in Liver Transplantation
Kulkarni S, Cronin D. Ethics in Liver Transplantation. Seminars In Liver Disease 2006, 26: 234-238. PMID: 16850372, DOI: 10.1055/s-2006-947299.Peer-Reviewed Original ResearchConceptsEnd-stage liver diseaseDeceased donor liversLiver transplantationLiver diseaseManagement of comorbiditiesDeceased donor kidneysGraft survivalPreferred therapyLifesaving therapyCurrent allocation systemSurgical techniqueTransplantationPatientsLiverTherapyDiseaseInadequate supplyDeficiencyComorbiditiesImmunosuppressionMELDKidneyMortalitySuch deficienciesSpectacular improvement
1999
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience
Woodle E, Buell J, Siegel C, Kulkarni S, Kopelan A, Grewal H. Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience. Transplantation Proceedings 1999, 31: 84-85. PMID: 10576053, DOI: 10.1016/s0041-1345(99)00803-9.Peer-Reviewed Original ResearchAFRICAN-AMERICAN COMPARED TO CAUCASIAN RESPONSE TO CORTICOSTEROID WITHDRAWAL FOLLOWING TACROLIMUS THERAPY FOR REFRACTORY RENAL REJECTION
Buell J, Mead J, Yoshida A, Kulkarni S, Kristo B, Kim E, Siegel C, Fisher J, Turner C, Bruce D, Cronin D, Millis J, Thistlethwaite J, Bruce D, Woodle E. AFRICAN-AMERICAN COMPARED TO CAUCASIAN RESPONSE TO CORTICOSTEROID WITHDRAWAL FOLLOWING TACROLIMUS THERAPY FOR REFRACTORY RENAL REJECTION. Transplantation 1999, 67: s163. DOI: 10.1097/00007890-199904150-00650.Peer-Reviewed Original Research